http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9217258-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef902e1469b5b21697baef3c286dea3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a49f08f9182c02c072d71ac104f1f92
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61G10-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61G10-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E04H3-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E04H3-08
filingDate 2010-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e39159643d673528299f7da403b2159e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33ad13e298245f2915f38c7dec35918c
publicationDate 2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9217258-B2
titleOfInvention Method and chamber for exposure to non-allergic rhinitis trigger environments
abstract The present invention is a method and chamber for exposure of human subjects to non-allergic rhinitis (“NAR”) trigger environments. The method occurs in a NAR chamber and involves tests that expose subjects to environmental triggers known to induce NAR symptoms. The chamber may be an enclosure capable of housing multiple subjects, constructed to facilitate the NAR tests and/or challenges and operable to create one or more NAR environments within the chamber. A different NAR environment may be required for each test. The chamber may facilitate the creation and containment of a specific NAR environment relating to a NAR test and/or challenge within the chamber for a particular period of time and achieve air-flow therein whereby subjects positioned within the chamber may be exposed to a NAR trigger environment in a virtually consistent manner. NAR tests and challenges may be assessed and the results thereof may be stored, compiled and/or reported.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016242979-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10219961-B2
priorityDate 2009-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10314241-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007286804-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129709128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129360771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129809280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129623647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127667887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128912737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128128716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128377695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128857037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6054

Total number of triples: 38.